Cartesian Therapeutics (NASDAQ: RNAC)
$10.48
(-7.1%)
-$0.80
Price as of August 7, 2025, 3:57 p.m. ET
Cartesian Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Cartesian Therapeutics Company Info
Cartesian Therapeutics, Inc. operates as a clinical-stage biotechnology company. It provides RNA cell therapies for the treatment of autoimmune diseases. The company is headquartered in Gaithersburg, MD.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.